Webinar – The Next Level: Optimizations of a Platform for CHO Cell Line Generation

Watch our webinar on demand now. Dr. Cornelia Lindner, Sartorius Stedim Cellca, discusses the process of optimizing a platform for CHO cell line generation. Presenter Cornelia Lindner, Team Lead Operations, Sartorius Stedim Cellca Description The market for therapeutic proteins is steadily growing and biological formats are getting more complex, resulting in a high demand for More

Webinar – Upgrading Your Recombinant Protein Expression: Expert Advice on Optimizing Mammalian Cell-based Production

Watch our webinar on demand: Upgrading your recombinant protein expression, with expert advice on optimizing mammalian cell-based production. Presenters Dr. Christoph Zehe, Lead Scientist for Cell Line Development at Sartorius Stedim Cellca GmbH, Germany Dr. Beate Stern, CSO for Uni Targeting Research AS, Norway Description In this webinar, we will discuss the key factors for More

Implemeting ADCC assays in QC: When donor variability isn’t an option

Watch our on-demand webinar about single donor-derived KILR CD16 Effector Cells to ensure assay reproductibility for screening, characterization, and QC lot release antibody drugs. Presented by our expert scientists, Lisa Blackwood and Laura Munro, and co-hosted with DiscoverX. The webinar focuses on 2 qualification studies that were performed using these effectors to demonstrate accuracy and precision in different More

Biosimilars: Lessons Learned

A Quality by Design approach to de-risk biosimilar development Learn more about the evolving biosimilar development pathway and how a QbD approach ensures a step-wise, orthogonal process to de-risk development and improve speed to market. Watch on demand now

Sign-up to our newsletter to be the first to hear about our new services & offers

Sign-up to our newsletter to be the first to hear about our new services & offers

Enter your email address to subscribe to our newsletter which provides information about our services. By subscribing, you are agreeing to the processing of your personal information for this purpose as set out in our privacy policy